Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2025
CD83 suppresses endogenous March-I-dependent MHC class II ubiquitination, endocytosis, and degradation
Sunil Kaul, Nelson B Cole, Joanna Bandola-Simon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 10, 2010
Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells
Even Walseng, Kazuyuki Furuta, Berta Bosch, et al.
Scientific Reports
|
September 8, 2017
A TCR-based Chimeric Antigen Receptor
Even Walseng, Hakan Köksal, Ibrahim M Sektioglu, et al.
Nature Communications
|
October 25, 2017
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates
Alex R Nanna, Xiuling Li, Even Walseng, et al.
The Journal of Biological Chemistry
|
July 23, 2016
Chemically Programmed Bispecific Antibodies in Diabody Format
Even Walseng, Christopher G Nelson, Junpeng Qi, et al.
Oncoimmunology
|
July 29, 2016
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
Nadia Mensali, Fan Ying, Vincent Oei Yi Sheng, et al.
Mabs
|
February 26, 2026
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
Rajesh K Mistry, Chendi Nui, Giulia Lambiase, et al.
Mabs
|
November 6, 2023
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C<sub>H</sub>1-C<sub>λ</sub> interface
John D Bagert, Vaheh Oganesyan, Chi-I Chiang, et al.
Mabs
|
October 8, 2025
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design
Peng Zhao, John Schardt, Chi-I Chiang, et al.
Mabs
|
August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release
John S Schardt, Even Walseng, Kim Le, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America
|
May 21, 2025
CD83 suppresses endogenous March-I-dependent MHC class II ubiquitination, endocytosis, and degradation
Sunil Kaul, Nelson B Cole, Joanna Bandola-Simon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 10, 2010
Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells
Even Walseng, Kazuyuki Furuta, Berta Bosch, et al.
Scientific Reports
|
September 8, 2017
A TCR-based Chimeric Antigen Receptor
Even Walseng, Hakan Köksal, Ibrahim M Sektioglu, et al.
Nature Communications
|
October 25, 2017
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates
Alex R Nanna, Xiuling Li, Even Walseng, et al.
The Journal of Biological Chemistry
|
July 23, 2016
Chemically Programmed Bispecific Antibodies in Diabody Format
Even Walseng, Christopher G Nelson, Junpeng Qi, et al.
Oncoimmunology
|
July 29, 2016
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
Nadia Mensali, Fan Ying, Vincent Oei Yi Sheng, et al.
Mabs
|
February 26, 2026
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
Rajesh K Mistry, Chendi Nui, Giulia Lambiase, et al.
Mabs
|
November 6, 2023
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C<sub>H</sub>1-C<sub>λ</sub> interface
John D Bagert, Vaheh Oganesyan, Chi-I Chiang, et al.
Mabs
|
October 8, 2025
Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design
Peng Zhao, John Schardt, Chi-I Chiang, et al.
Mabs
|
August 29, 2024
IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release
John S Schardt, Even Walseng, Kim Le, et al.
Page
of 2